Post hoc analysis of Japanese patients from the placebo-controlled PREVAIL trial of enzalutamide in patients with chemotherapy-naive, metastatic castration-resistant prostate cancer—updated results

A post hoc analysis of interim results from PREVAIL, a Phase III, double-blind, placebo-controlled trial of men with metastatic castration-resistant prostate cancer, demonstrated that the treatment effects, safety and pharmacokinetics of enzalutamide in Japanese patients were generally consistent wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kimura, Go, Ueda, Takeshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5444320/
https://www.ncbi.nlm.nih.gov/pubmed/28003320
http://dx.doi.org/10.1093/jjco/hyw187

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5444320/
https://www.ncbi.nlm.nih.gov/pubmed/28003320
http://dx.doi.org/10.1093/jjco/hyw187

Ejemplares similares